1,677 results on '"Beriwal, Sushil"'
Search Results
152. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer
153. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer
154. Utilization of functional MRI in the diagnosis and management of cervical cancer
155. Saturday, June 18, 20229:30 AM - 10:30 AM GPP06 Presentation Time: 9:30 AM
156. Dosimetry and Toxicity Outcomes in Patients Treated with Hypofractionated Regional Nodal Irradiation for Breast Cancer: What is the Best Dose-Volume Limit to Minimize Risks of Radiation Pneumonitis?
157. PO35 Presentation Time: 10:30 AM
158. PO41 Presentation Time: 4:45 PM
159. MSS07 Presentation Time: 4:15 PM
160. GSOR14 Presentation Time: 11:35 AM
161. Friday, June 17, 202210:00 AM - 12 PMPO01
162. PSOR2 Presentation Time: 11:35 AM
163. Erratum: “AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy—Considerations from simulation to treatment” https://doi.org/10.1002/mp.15713
164. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival
165. Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node–Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patterns in the Positron Emission Tomography/Computed Tomography Era
166. National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements
167. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: A National Cancer Data Base (NCDB) study
168. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma
169. Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria
170. Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer
171. Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification
172. The Integration of 3D Imaging with Conformal Radiotherapy for Vulvar and Vaginal Cancer
173. Cost effectiveness of treatment strategies for high risk prostate cancer
174. The role of adjuvant treatment for early-stage uterine clear cell carcinoma (405)
175. Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer (089)
176. Surgical margins after neoadjuvant chemoradiotherapy for locally advanced vulvar carcinoma: What is an adequate margin? (531)
177. Adjuvant therapy in early uterine serous carcinoma (324)
178. SPCR-01 RAPIDPLAN HIPPOCAMPAL SPARING WHOLE BRAIN MODEL VERSION 2 - HOW FAR CAN WE REDUCE THE DOSE?
179. Indications for Adjuvant Radiation Therapy in Patients With pN0(i +) Adenocarcinoma of the Endometrium
180. Combination of Knife and Rays with MRI-Guided Ablative Brachytherapy
181. Rare presentation of metastatic cervical cancer to the right upper extremity skeletal muscle and gluteal adipose tissue
182. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy
183. Extended (5-year) Outcomes of Accelerated Partial Breast Irradiation Using MammoSite Balloon Brachytherapy: Patterns of Failure, Patient Selection, and Dosimetric Correlates for Late Toxicity
184. Impact of facility volume on therapy and survival for locally advanced cervical cancer
185. Standardizing Assessment of Gynecologic Brachytherapy Contours: A Pilot Study in Contour Competency Assessment for Radiation Oncology Residents
186. Overview of North American Trials
187. The Future of Altered Fractionation
188. Utilizing clinical pathways and web-based conferences to improve quality of care in a large integrated network using breast cancer radiation therapy as the model
189. Current Concepts in Radiation Therapy for Early-Stage Endometrial Cancer
190. AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy—Considerations from simulation to treatment
191. In Regard to Schumacher et al.
192. Are Radiation Therapy Oncology Group Para-aortic Contouring Guidelines for Pancreatic Neoplasm Applicable to Other Malignancies—Assessment of Nodal Distribution in Gynecological Malignancies
193. Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: A cost-effectiveness analysis
194. Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer
195. Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse
196. Prostate-specific antigen spikes with 131Cs brachytherapy. Is there a difference with other radioisotopes?
197. Complete metabolic response after definitive radiation therapy for cervical cancer: Patterns and factors predicting for recurrence
198. Contouring inguinal and femoral nodes; how much margin is needed around the vessels?
199. High-dose-rate interstitial computed tomography–based brachytherapy for the treatment of cervical cancer: Early results
200. Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.